HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Moyamoya disease associated with persistent primitive trigeminal artery. Report of two cases.

Abstract
Two cases of moyamoya disease associated with persistent primitive trigeminal artery (PTA) are reported. The first patient was a 44-year-old man who experienced a sudden severe headache brought about by an intracerebral hematoma in the left temporoparietal lobe. Four-vessel study showed a right-sided PTA and moyamoya disease. The second patient was a 56-year-old woman with similar symptoms and a hematoma in the right temporoparietal lobe. Four-vessel study showed a left-sided PTA and moyamoya disease. Among the 212 PTA cases reported in the literature, none has been associated with moyamoya disease. Moreover, there are no cases of moyamoya disease among the 119 cases of persistent primitive hypoglossal artery (PHA), which is thought to be a vascular anomaly fundamentally similar to PTA. None of the 907 cases of moyamoya disease reported in Japan has been associated with either PTA or PHA. Nonetheless, the embryonic stage when PTA or PHA normally disappears partially overlaps that period when moyamoya-like vascular anomalies have been thought to arise. The possible developmental relationship between these two varieties of vascular abnormality is discussed.
AuthorsR Kwak, S Kadoya
JournalJournal of neurosurgery (J Neurosurg) Vol. 59 Issue 1 Pg. 166-71 (Jul 1983) ISSN: 0022-3085 [Print] United States
PMID6864274 (Publication Type: Case Reports, Journal Article)
Topics
  • Adult
  • Arterial Occlusive Diseases (diagnostic imaging)
  • Cerebral Angiography
  • Cerebral Arteries (abnormalities)
  • Cerebral Hemorrhage (complications, diagnostic imaging)
  • Humans
  • Intracranial Aneurysm (complications, diagnostic imaging)
  • Male
  • Moyamoya Disease (diagnostic imaging)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: